Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 16841–16860 of 17,529 recalls

March 4, 2013· CareFusion 213, LLC

Recalled Item: SEPP 70% Isopropanol (isopropyl alcohol) 70% v/v

The Issue: Labeling: Not Elsewhere Classified: This product is misbranded

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 2, 2013· Physicians Total Care, Inc.

Recalled Item: Voltaren 1% Gel

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration Date;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: FIBRICOR (fenofibric acid) Tablets

The Issue: Labeling: Incorrect instructions; an error in section 5.11

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 27, 2013· Baxter Healthcare Corp.

Recalled Item: 0.9% Sodium Chloride Injection

The Issue: Labeling Wrong Barcode; It may display wrong product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: Fenofibric Acid

The Issue: Labeling: Incorrect instructions; an error in section 5.11

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 27, 2013· Mutual Pharmaceutical Company, Inc.

Recalled Item: Fenofibric Acid

The Issue: Labeling: Incorrect instructions; an error in section 5.11

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 26, 2013· Sanofi-Synthelabo

Recalled Item: Rifadin (rifampin) capsules

The Issue: Subpotent Drug: During review of retain samples, the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Hospira Inc.

Recalled Item: QUELICIN (succinylcholine chloride) Injection

The Issue: Lack of Assurance of Sterility: Loose crimp applied

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Hospira Inc.

Recalled Item: Furosemide Injection

The Issue: Lack of Assurance of Sterility: Loose crimp applied

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Hospira Inc.

Recalled Item: Diazepam Injection

The Issue: Lack of Assurance of Sterility: Loose crimp applied

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Teva Pharmaceuticals USA, Inc.

Recalled Item: Cefdinir for Oral Suspension

The Issue: Defective Container: This recall is being carried out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Hospira Inc.

Recalled Item: Sodium Acetate Injection

The Issue: Lack of Assurance of Sterility: Loose crimp applied

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 26, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets

The Issue: Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 25, 2013· Hospira Inc.

Recalled Item: Propofol Injectable Emulsion

The Issue: Presence of Particulate Matter: Visible particulate embedded in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 22, 2013· Lupin Pharmaceuticals Inc.

Recalled Item: Ethambutol Hydrochloride Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 22, 2013· Petnet Solution Inc

Recalled Item: Fludeoxyglucose F 18 Injection USP

The Issue: cGMP Deviation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 19, 2013· Novartis Consumer Health

Recalled Item: Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1%

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 19, 2013· Novartis Consumer Health

Recalled Item: Voltaren Gel (diclofenac sodium topical gel) 1%

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 19, 2013· Novartis Consumer Health

Recalled Item: Target Up & Up

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 19, 2013· Novartis Consumer Health

Recalled Item: Novartis Lamisil AT Cream

The Issue: Labeling: Incorrect or Missing Lot and/or Expiration date;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund